BioSpace News Archive

Helsinn and Recordati Rare Diseases announce that a co-sponsored Symposium, organized by the two companies at the European Society for Dermatological Research Annual Meeting, , will provide a better knowledge of Chlormethine Gel’s mode of action as well as guidance on the management of the Chlormethine gel induced dermatitis.

Herbert ‘Herb’ Heyneker, Chairman of the Board of Directors at Mimetas and Dutch biotech pioneer, has been honored by the Dutch Monarchy for his contributions and commitment to biotechnology in the Netherlands and Leiden.

Eisai Co., Ltd. has announced that latest data on lemborexant, an investigational sleep-wake regulation agent being studied for the treatment of sleep-wake disorders, including insomnia and Irregular Sleep-Wake Rhythm Disorder associated with Alzheimer’s disease/dementia will be presented at World Sleep Congress, from September 20 to 25 in Vancouver, Canada.

Firma Clinical Research, a niche service provider, is partnering with The Myositis Association on a multi-faceted project to better integrate the experience of patients into the training of clinical trial investigators and support providers.

Flexion Therapeutics, Inc. announced its sponsorship of “Prescribed to Death: A Memorial to the Victims of the Opioid Crisis.” The national traveling exhibit is dedicated to building awareness of the continuing opioid crisis in the United States and was developed by the National Safety Council (NSC) as part of the Stop Everyday Killers public education campaign.

Tthe New York-based company Creative Peptides announced the release of peptide library and peptide array on September 24, 2019, providing powerful tools for scientists who are involved with protein–protein interaction research, drug R&D and many other possible applications associated with biochemicals and pharmaceuticals.

Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, announces its unaudited interim results for the six months ended 30 June 2019.

CloudLIMS, a leading laboratory data management informatics provider, announces the release of the Training Module for its Laboratory Information Management System, CloudLIMS.

Data to be presented at inaugural STORM Therapeutics RNA Epigenetics in Human Disease Conference in Cambridge, UK

Software enhancements offer a complete application for CMC decision support, improvements for analytical data processing and analysis, and a move to 64-bit architecture.